Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jilin Galaxy Pharmaceutical Co., Ltd. is a pharmaceutical manufacturing company headquartered in Changchun, China, and a subsidiary of Galaxy Biomedical Investment. The company specializes in the development and production of biochemical drugs, chemical pharmaceuticals, and traditional Chinese medicines (TCM). Its product portfolio is primarily focused on hepatology and gastroenterology, featuring key products such as silymarin (Yiganling) for liver protection and pancreatin for digestive support. Jilin Galaxy operates several GMP-certified production lines and is a significant supplier of biochemical raw materials. The company leverages its location in the Jilin pharmaceutical cluster to maintain a robust supply chain for animal-derived medicinal components.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jilin Galaxy Pharmaceutical.